Myomo Historical Income Statement
| MYO Stock | USD 6.38 0.17 2.74% |
Historical analysis of Myomo income statement accounts such as Selling And Marketing Expenses of 3.4 M can show how well Myomo Inc performed in making a profits. Evaluating Myomo income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Myomo's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Myomo Inc latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Myomo Inc is a good buy for the upcoming year.
Myomo |
About Myomo Income Statement Analysis
Myomo Inc Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Myomo shareholders. The income statement also shows Myomo investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Myomo Income Statement Chart
Add Fundamental
Total Revenue
Total revenue comprises all receipts Myomo Inc generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Gross Profit
Gross profit is a required income statement account that reflects total revenue of Myomo Inc minus its cost of goods sold. It is profit before Myomo operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Income Before Tax
Income Before Tax which can also be referred as pre-tax income is reported on Myomo income statement and is an important metric when analyzing Myomo Inc profitability. Accounting techniques because taxes can be complex, and not perfectly consistent from one company to company, an analyst may use pre-tax income as a more stable measure of profitability.Most accounts from Myomo's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Myomo Inc current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Myomo Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. At this time, Myomo's Total Other Income Expense Net is very stable compared to the past year. As of the 12th of December 2024, Interest Income is likely to grow to about 620.3 K, while Selling General Administrative is likely to drop about 10.4 M.
| 2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 10.3M | 10.3M | 13.2M | 13.8M | Total Revenue | 13.9M | 15.6M | 19.2M | 20.2M |
Myomo income statement Correlations
Click cells to compare fundamentals
Myomo Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Myomo income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Depreciation And Amortization | (99.4K) | 108.7K | 336.0K | 542.6K | 517.7K | 543.6K | |
| Interest Expense | 113.6K | 474.7K | 15.3K | 88.7K | 102.0K | 172.4K | |
| Selling General Administrative | 11.3M | 13.0M | 14.4M | 14.4M | 16.0M | 10.4M | |
| Selling And Marketing Expenses | 301.7K | 841.3K | 3.6M | 4.1M | 3.2M | 3.4M | |
| Total Revenue | 3.8M | 7.6M | 13.9M | 15.6M | 19.2M | 20.2M | |
| Gross Profit | 2.9M | 5.0M | 10.3M | 10.3M | 13.2M | 13.8M | |
| Other Operating Expenses | 14.6M | 18.1M | 24.1M | 26.2M | 27.5M | 15.8M | |
| Operating Income | (10.8M) | (10.5M) | (10.3M) | (10.7M) | (8.2M) | (8.6M) | |
| Net Income From Continuing Ops | (10.7M) | (11.6M) | (10.4M) | (10.7M) | (7.9M) | (8.2M) | |
| Ebit | (10.8M) | (11.3M) | (10.3M) | (10.7M) | (8.6M) | (9.0M) | |
| Research Development | 2.2M | 1.7M | 2.6M | 2.5M | 2.6M | 2.0M | |
| Ebitda | (10.9M) | (11.2M) | (9.9M) | (10.1M) | (8.1M) | (8.5M) | |
| Cost Of Revenue | 917.6K | 2.6M | 3.5M | 5.3M | 6.1M | 6.4M | |
| Total Operating Expenses | 13.7M | 15.5M | 20.6M | 20.9M | 21.4M | 13.6M | |
| Income Before Tax | (10.7M) | (11.6M) | (10.3M) | (10.7M) | (8.0M) | (8.4M) | |
| Total Other Income Expense Net | 82.0K | (1.1M) | (15.3K) | 21.1K | 240.0K | 252.0K | |
| Net Income Applicable To Common Shares | (11.5M) | (12.2M) | (11.0M) | (10.7M) | (9.6M) | (10.1M) | |
| Net Income | (10.6M) | (12.0M) | (10.4M) | (10.7M) | (8.1M) | (8.6M) | |
| Income Tax Expense | (82.0K) | 474.7K | 88.9K | 69.9K | 156.0K | 148.2K | |
| Interest Income | 82K | 352K | 15.3K | 22.2K | 342.8K | 620.3K | |
| Net Interest Income | (112.5K) | (474.7K) | (15.3K) | 88.7K | 342.8K | 359.9K | |
| Reconciled Depreciation | 95.1K | 108.7K | 336.0K | 542.6K | 582.7K | 611.9K |
Pair Trading with Myomo
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Myomo position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Myomo will appreciate offsetting losses from the drop in the long position's value.Moving together with Myomo Stock
Moving against Myomo Stock
| 0.77 | DRIO | DarioHealth Corp | PairCorr |
| 0.69 | EDAP | EDAP TMS SA | PairCorr |
| 0.63 | VERO | Venus Concept | PairCorr |
| 0.38 | CI | Cigna Corp Downward Rally | PairCorr |
| 0.31 | VTAK | Catheter Precision Earnings Call This Week | PairCorr |
The ability to find closely correlated positions to Myomo could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Myomo when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Myomo - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Myomo Inc to buy it.
The correlation of Myomo is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Myomo moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Myomo Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Myomo can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Myomo Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Myomo. If investors know Myomo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Myomo listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.23) | Revenue Per Share 0.835 | Quarterly Revenue Growth 0.813 | Return On Assets (0.31) | Return On Equity (0.83) |
The market value of Myomo Inc is measured differently than its book value, which is the value of Myomo that is recorded on the company's balance sheet. Investors also form their own opinion of Myomo's value that differs from its market value or its book value, called intrinsic value, which is Myomo's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Myomo's market value can be influenced by many factors that don't directly affect Myomo's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Myomo's value and its price as these two are different measures arrived at by different means. Investors typically determine if Myomo is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Myomo's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.